NASDAQ:CKPT
Checkpoint Therapeutics, Inc.
- Stock
Last Close
2.66
26/07 20:00
Market Cap
82.24M
Beta: 1.44
Volume Today
471.19K
Avg: 295.57K
PE Ratio
−0.73
PFCF: −0.75
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | |||||||||
average payables | 2.10M - | 4.58M 117.65% | 9.73M 112.43% | 8.52M 12.49% | 5.58M 34.50% | 12.21M 118.85% | 19.40M 58.91% | 15.49M 20.14% | ||
average receivables | 443K - | 576K 30.02% | 931.50K 61.72% | 779K 16.37% | 23K 97.05% | 18.50K 19.57% | 45K 143.24% | 36.50K 18.89% | ||
book value per share | 18.99 - | 14.99 21.05% | 6.65 55.65% | 4.13 37.82% | 5.34 29.12% | 6.34 18.70% | 3.91 38.26% | -2.21 156.36% | -0.70 68.43% | |
capex per share | -1.03 - | -1.47 41.89% | -0.18 87.94% | |||||||
capex to depreciation | -9.75 - | |||||||||
capex to operating cash flow | 2.28 - | 0.32 86.06% | 0.03 91.85% | |||||||
capex to revenue | -4.28 - | -1.23 71.27% | -0.23 81.14% | |||||||
cash per share | 20.64 - | 16.29 21.10% | 8.50 47.81% | 7.70 9.37% | 7.39 4.11% | 7.30 1.13% | 7.20 1.42% | 1.37 81.03% | 0.26 80.75% | |
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 40.21 - | 116.60 189.97% | 70.04 39.93% | 159.49 127.72% | 5.56 96.52% | 6.83 22.90% | 23.15 239.05% | 138.78 499.39% | ||
debt to assets | 0.05 - | |||||||||
debt to equity | 0.05 - | |||||||||
dividend yield | ||||||||||
earnings yield | -0.11 - | -0.13 14.57% | -0.26 98.28% | -0.70 170.83% | -0.40 42.16% | -0.16 61.66% | -0.24 54.28% | -1.48 518.98% | -1.21 18.49% | |
enterprise value | 74.18M - | 137.27M 85.04% | 68.54M 50.07% | 29.97M 56.27% | 34.65M 15.59% | 107.18M 209.36% | 181.72M 69.55% | 33.08M 81.80% | 37.99M 14.84% | |
enterprise value over ebitda | -5.61 - | -6.21 10.59% | -3.02 51.30% | -0.82 73.01% | -1.39 70.90% | -4.62 231.34% | -3.20 30.65% | -0.61 80.84% | -0.73 18.66% | |
ev to operating cash flow | -66.95 - | -13.80 79.40% | -4.43 67.87% | -1.16 73.80% | -1.62 39.56% | -6.48 299.49% | -6.91 6.68% | -0.57 91.68% | -0.80 38.89% | |
ev to sales | 125.74 - | 53.41 57.52% | 39.73 25.61% | 8.55 78.48% | 20.28 137.27% | 100.26 394.28% | 678.07 576.31% | 172.30 74.59% | 368.86 114.08% | |
free cash flow per share | -1.49 - | -6.09 309.14% | -7.01 15.24% | -9.04 28.88% | -6.05 33.01% | -2.96 51.03% | -3.46 16.71% | -6.51 88.27% | -2.54 61.02% | |
free cash flow yield | -0.03 - | -0.08 155.71% | -0.18 137.60% | -0.50 174.75% | -0.35 29.12% | -0.11 68.22% | -0.11 0.55% | -1.27 1,045.84% | -1.11 13.02% | |
graham net net | 18.92 - | 14.87 21.41% | 5.79 61.04% | 3.52 39.23% | 5.09 44.66% | 6.01 18.08% | 3.78 37.08% | -2.34 161.77% | -0.72 69.19% | |
graham number | 49.30 - | 59.31 20.30% | 38.73 34.70% | 34.42 11.12% | 28.92 15.99% | 24.22 16.26% | 25.60 5.73% | 19.38 24.29% | 6.58 66.04% | |
income quality | 0.08 - | 0.44 455.42% | 0.68 53.91% | 0.71 4.07% | 0.86 21.88% | 0.72 17.08% | 0.46 35.27% | 0.92 97.99% | 0.92 0.12% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -56.26 - | -64.43 14.52% | -13.59 - | |||||||
interest debt per share | 1.11 - | 0.16 85.57% | 0.49 - | |||||||
inventory turnover | ||||||||||
invested capital | 0.05 - | |||||||||
market cap | 122.13M - | 172.35M 41.12% | 87.76M 49.08% | 51.97M 40.79% | 60.72M 16.85% | 147.95M 143.65% | 236.46M 59.82% | 45.15M 80.91% | 42.92M 4.94% | |
net current asset value | 46.40M - | 32.30M 30.37% | 15.04M 53.44% | 11.81M 21.51% | 18.85M 59.64% | 35.38M 87.72% | 29.75M 15.92% | -19.48M 165.50% | -13.05M 33.03% | |
net debt to ebitda | 3.63 - | 1.59 56.27% | 0.85 46.56% | 0.60 29.38% | 1.05 75.29% | 1.76 67.47% | 0.96 45.09% | 0.22 76.79% | 0.09 57.81% | |
net income per share | -5.69 - | -10.43 83.32% | -10.03 3.84% | -12.74 27.04% | -6.96 45.34% | -4.11 40.93% | -7.45 81.06% | -7.57 1.70% | -2.77 63.47% | |
operating cash flow per share | -0.45 - | -4.62 918.17% | -6.84 48.00% | -9.04 32.21% | -6.05 33.01% | -2.96 51.03% | -3.46 16.71% | -6.51 88.27% | -2.54 61.02% | |
payables turnover | ||||||||||
receivables turnover | 9.08 - | 3.13 65.51% | 5.21 66.48% | 2.29 56.09% | 65.69 2,770.53% | 53.45 18.64% | 15.76 70.51% | 2.63 83.32% | ||
research and ddevelopement to revenue | 19.19 - | 7.89 58.91% | 11.06 40.27% | 9.60 13.22% | 11.31 17.87% | 15.30 35.20% | 180.79 1,081.93% | 259.51 43.54% | 422.97 62.99% | |
return on tangible assets | -0.27 - | -0.62 127.64% | -1.06 69.64% | -1.46 37.92% | -0.91 37.60% | -0.54 40.86% | -1.02 88.47% | -5.03 395.59% | -9.64 91.47% | |
revenue per share | 0.24 - | 1.19 393.88% | 0.76 36.07% | 1.23 61.00% | 0.48 60.60% | 0.19 60.42% | 0.04 81.59% | 0.02 38.35% | 0.01 74.71% | |
roe | -0.30 - | -0.70 132.21% | -1.51 116.85% | -3.08 104.31% | -1.30 57.66% | -0.65 50.23% | -1.90 193.27% | 3.43 280.45% | 3.97 15.70% | |
roic | -0.28 - | -0.69 149.39% | -1.51 120.70% | -3.07 102.58% | -1.31 57.25% | -0.65 50.25% | -1.91 192.03% | 3.20 267.93% | 4.00 24.94% | |
sales general and administrative to revenue | 4.22 - | 1.74 58.78% | 3.14 80.74% | 1.88 40.15% | 4.23 125.23% | 7.41 74.91% | 31.86 330.11% | 45.31 42.23% | 84.32 86.09% | |
shareholders equity per share | 18.99 - | 14.99 21.05% | 6.65 55.65% | 4.13 37.82% | 5.34 29.12% | 6.34 18.70% | 3.91 38.26% | -2.21 156.36% | -0.70 68.43% | |
stock based compensation to revenue | 5.51 - | 1.50 72.70% | 1.81 20.09% | 0.57 68.53% | 1.83 221.29% | 2.60 42.32% | 11.71 350.10% | 15.23 30.11% | 28.13 84.69% | |
tangible asset value | 46.40M - | 32.30M 30.37% | 15.04M 53.44% | 11.81M 21.51% | 18.85M 59.64% | 35.38M 87.72% | 29.75M 15.92% | -19.48M 165.50% | -13.05M 33.03% | |
tangible book value per share | 18.99 - | 14.99 21.05% | 6.65 55.65% | 4.13 37.82% | 5.34 29.12% | 6.34 18.70% | 3.91 38.26% | -2.21 156.36% | -0.70 68.43% | |
working capital | 48.86M - | 32.30M 33.89% | 15.04M 53.44% | 11.81M 21.51% | 18.85M 59.64% | 35.38M 87.72% | 29.75M 15.92% | -19.48M 165.50% | -13.05M 33.03% |
All numbers in USD (except ratios and percentages)